World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma AB (publ) lanserar långsiktigt aktiesparprogram för anställda
Read more >> -
Xbrane Biopharma AB (publ) launch a long-term share savings program for employees
Read more >> -
Xbrane Biopharma announces a directed new share issue of SEK 20 million
Read more >> -
Xbrane Biopharma genomför en riktad nyemission om 20 MSEK
Read more >> -
Kommuniké från Årsstämma i Xbrane Biopharma AB (publ)
Read more >>
Events
-
09 Jan 2017
J.P. Morgan 35th Annual Healthcare Conference, January 9-12
Read more >>
X
